May 9 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2016 Mar 31, 2015 Mar 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 29.73 25.97 31.00 14.11
(+14.5 pct) (+8.6 pct) (+4.3 pct) (+6.4 pct)
Operating 2.67 2.30 2.70 744 mln
(+15.8 pct) (+17.8 pct) (+1.2 pct) (+8.8 pct)
Recurring 3.30 2.77 3.05 844 mln
(+19.1 pct) (+23.8 pct) (-7.6 pct) (-2.7 pct)
Net
Net 1.33 963 mln 1.30 68 mln
(+38.4 pct) (-34.4 pct) (-2.6 pct) (-52.6 pct)
EPS 11.08 yen 8.01 yen 10.80 yen 0.57 yen
Ann Div 1.80 yen 1.50 yen 1.80 yen
-Q2 Div NIL NIL NIL
-Q4 Div 1.80 yen 1.50 yen 1.80 yen
NOTE - Takara Bio Inc..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T
((Tokyo Headline News Desk +813 6441 1812))